Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | meticrane | 4165 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | meticrane | 4165 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | meticrane | 4165 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | meticrane | 4165 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | meticrane | 4165 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | meticrane | 4165 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | meticrane | 4165 | drug-path |
SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | sulfaphenazole | 5335 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfaphenazole | 5335 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | sulfaphenazole | 5335 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | sulfaphenazole | 5335 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfaphenazole | 5335 | drug-path |
Shigellosis | 0 | map05131 | sulfaphenazole | 5335 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | sulfaphenazole | 5335 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfaphenazole | 5335 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulfaphenazole | 5335 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | sulfaphenazole | 5335 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | sulfaphenazole | 5335 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | procaine | 4914 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | procaine | 4914 | drug-path |